Scientists Puzzle Over Ancient Ossuary

© Royal Ontario Museum, Brian Boyle, MPAIn October 2002, a group of archaeologists held a press conference in Washington, DC, to announce a startling discovery. A limestone box had been discovered in Israel with the inscription "James the son of Joseph the brother of Jesus." It was a stunning find: the first physical evidence of Jesus. The news swept through the field of biblical archaeology. The ossuary, a container for the bones of the deceased meant to be kept in a cave, was already on i

Written bySam Jaffe
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

© Royal Ontario Museum, Brian Boyle, MPA

In October 2002, a group of archaeologists held a press conference in Washington, DC, to announce a startling discovery. A limestone box had been discovered in Israel with the inscription "James the son of Joseph the brother of Jesus." It was a stunning find: the first physical evidence of Jesus. The news swept through the field of biblical archaeology. The ossuary, a container for the bones of the deceased meant to be kept in a cave, was already on its way to the Royal Ontario Museum, where it was to be displayed for a few months. The museum's press release said, "It may be the most important find in the history of new testament archaeology."

More than a year later, in June of 2003, the Israel Antiquities Authority (IAA) announced an even more stunning piece of news. A multidisciplinary committee of Israeli scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies